no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Comparison of Inhibitory Effects of Irbesartan and Atorvastatin Treatment on the Renin Angiotensin System (RAS) in Veins: A Randomized Double-Blind Crossover Trial in Healthy Subjects
|
Schindler, Christoph |
|
2007 |
47 |
1 |
p. 112-120 |
article |
2 |
Comparison of the Stability, Efficacy, and Adverse Effect Profile of the Innovator 0.005% Latanoprost Ophthalmic Solution and a Novel Cyclodextrin-containing Formulation
|
Gonzalez, Jaime R. |
|
2007 |
47 |
1 |
p. 121-126 |
article |
3 |
Dose-Proportional Intraindividual Single and Repeated-Dose Pharmacokinetics of Roflumilast, an Oral, Once-Daily Phosphodiesterase 4 Inhibitor
|
Bethke, Thomas D. |
|
2007 |
47 |
1 |
p. 26-36 |
article |
4 |
Dose-Proportional Pharmacokinetics of d-threo-Methylphenidate After a Repeated-Action Release Dosage Form
|
Tuerck, Dietrich |
|
2007 |
47 |
1 |
p. 64-69 |
article |
5 |
Effect of Polymorphic CYP3A5 Genotype on the Single-Dose Simvastatin Pharmacokinetics in Healthy Subjects
|
Kim, Kyoung-Ah |
|
2007 |
47 |
1 |
p. 87-93 |
article |
6 |
Highly Variable Mycophenolate Mofetil Bioavailability Following Nonmyeloablative Hematopoietic Cell Transplantation
|
Jacobson, Pamala |
|
2007 |
47 |
1 |
p. 6-12 |
article |
7 |
Oral Antidiabetic Drugs: Bioavailability Assessment of Fixed-Dose Combination Tablets of Pioglitazone and Metformin. Effect of Body Weight, Gender, and Race on Systemic Exposures of Each Drug
|
Karim, Aziz |
|
2007 |
47 |
1 |
p. 37-47 |
article |
8 |
Oral Antidiabetic Drugs: Effect of Food on Absorption of Pioglitazone and Metformin From a Fixed-Dose Combination Tablet
|
Karim, Aziz |
|
2007 |
47 |
1 |
p. 48-55 |
article |
9 |
Pharmacokinetics and Safety of Ketorolac Following Single Intranasal and Intramuscular Administration in Healthy Volunteers
|
McAleer, Sarah D. |
|
2007 |
47 |
1 |
p. 13-18 |
article |
10 |
Plasma and Cerebrospinal Fluid Concentrations of Indomethacin in Children After Intravenous Administration
|
Mannila, Anne |
|
2007 |
47 |
1 |
p. 94-100 |
article |
11 |
Population Pharmacokinetic-Based Dosing of Intravenous Busulfan in Pediatric Patients
|
Booth, Brian P. |
|
2007 |
47 |
1 |
p. 101-111 |
article |
12 |
Significant Pharmacokinetic and Pharmacodynamic Interaction of Warfarin With the NO-Independent sGC Activator HMR1766
|
Oberwittler, Heike |
|
2007 |
47 |
1 |
p. 70-77 |
article |
13 |
Single-Dose and Steady-State Pharmacokinetics of Fentanyl Buccal Tablet in Healthy Volunteers
|
Darwish, Mona |
|
2007 |
47 |
1 |
p. 56-63 |
article |
14 |
Systemic Availability of the Active Metabolite Hydroxy-Fasudil After Administration of Fasudil to Different Sites of the Human Gastrointestinal Tract
|
Hinderling, Peter H. |
|
2007 |
47 |
1 |
p. 19-25 |
article |
15 |
The Role of SN-38 Exposure, UGT1A1*28 Polymorphism, and Baseline Bilirubin Level in Predicting Severe Irinotecan Toxicity
|
Ramchandani, Roshni P. |
|
2007 |
47 |
1 |
p. 78-86 |
article |
16 |
Vildagliptin Does Not Affect C-Peptide Clearance in Patients With Type 2 Diabetes
|
He, Yan-Ling |
|
2007 |
47 |
1 |
p. 127-131 |
article |